News | SummitMD

NIRS-IVUS Imaging Helps Detect Vulnerable Plaques, Patients at High Risk for Adverse Cardiac Events

PROSPECT II results presented at TCT Connect 2020 show combined intracoronary imaging helps identify lipid-rich non-flow limiting lesions associated with higher MACE risk

News | SummitMD

Coronary CTA on Asymptomatic Patients Provides Little to No Clinical Benefit

Asan Medical Center research team finds increasing rate of coronary CTAs on domestic asymptomatic patients but little subsequent diagnostic, survival benefit

News | SummitMD

Aspirin Alone Better for Post-TAVI Patients not on Anticoagulation: POPular TAVI

Study comparing aspirin+clopidogrel vs. aspirin shows aspirin alone reduced risk of all bleeding with no increased thrombotic risk for post-TAVI patients not on oral anticoagulation

News | SummitMD

2nd SGLT-2 Inhibitor Scores in HF as Empagliflozin Reduces Hospitalization, CV Death in HFrEF

EMPEROR-Reduced: diabetes drug empagliflozin shows significant CV, renal benefits in HFrEF regardless of diabetes status

News | ACT Program

1st Virtual ACT Program Held

The "A"san Medical Center Interventional "C"ardiology "T"raining Program (hereinafter referred to as ACT Program) was successfully held online for the first time for two days on June 19th (Fri) and 20th (Sat) by attracting approximately 600 participants.

News | TCTAP & AP VALVES 2020 Virtual

Choice of Stent Platforms in HBR Patients - Insights from the ONYX-ONE Trial

August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

News | TCTAP & AP VALVES 2020 Virtual

A New Algorithm from Japanese CTO-PCI Expert Registry

August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL